Antiretroviral drug treatment of CNS HIV-1 infection.
Aylin Yilmaz, Richard W Price, Magnus Gisslén
Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Smörslottsgatan 1, 416 85 Gothenburg, Sweden. aylin.yilmaz@gu.se
The Journal of antimicrobial chemotherapy 2012 FebThe advent of combination antiretroviral treatment has had a profound impact on CNS HIV infection and its clinical complications, but neurological impairment still occurs in patients on systemically effective combination therapy, and in some patients it may be important to consider antiretroviral drug entry and effects within the CNS. There are now data on the CNS exposure for most antiretroviral drugs. This review focuses on the CNS pharmacokinetics and pharmacodynamics of antiretroviral drugs in humans, and also discusses controversies in this field.
Citation
Aylin Yilmaz, Richard W Price, Magnus Gisslén. Antiretroviral drug treatment of CNS HIV-1 infection. The Journal of antimicrobial chemotherapy. 2012 Feb;67(2):299-311
Mesh Tags
Substances
PMID: 22160207
View Full Text
